Mogling Bio

Developer of cell-based therapeutics for blood cancer

placeWilmington, Delaware, United States calendar_todayFounded 2022 language moglingbio.com

Innovation

1 patent family — focus: Chemistry & metallurgy; filing pace active. Cited 36 times.

YearFilings
20251

Investor mix

2 investors on record; lead investors include Kizoo.

Investor typeCountShare
Venture capital150%
Other / undisclosed150%
Coming soon